Search results - 2 results

Low hepatitis C prevalence in Belgium: implications for treatment reimbursement and scale up.

order to guide decisions on DAA  reimbursement. METHODS: Residual sera were collected through clinical laboratories. We collected data on age, sex and district. HCV antibody status was determined with ...

Distribution of HCV genotypes in Belgium from 2008 to 2015.

However they are outdated, lack nationwide representativeness or were not conducted in the general population. METHODS: In order to determine the distribution of different circulating HCV genotypes in ...

QR code

QR code for this page URL